We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$8.4B
AUM Growth
+$1.66B
Cap. Flow
+$1.33B
Cap. Flow %
15.85%
Top 10 Hldgs %
61.33%
Holding
510
New
182
Increased
113
Reduced
52
Closed
146

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$79.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$74.4M
3
KVUE icon
Kenvue
KVUE
+$65.3M
4
ELF icon
e.l.f. Beauty
ELF
+$51.7M
5
GSK icon
GSK
GSK
+$46.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$96.3M
2
EXAS
Exact Sciences
EXAS
+$56.4M
3
PTCT icon
PTC Therapeutics
PTCT
+$34.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$28M
5
MDB icon
MongoDB
MDB
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 32.56%
2 Technology 5.44%
3 Consumer Discretionary 5.13%
4 Consumer Staples 2.69%
5 Communication Services 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRVL icon
451
Marvell Technology
MRVL
$196B
– –
-18,621
Closed -$1.57M
MTDR icon
452
Matador Resources
MTDR
$6.09B
– –
-43,917
Closed -$1.97M
NCLH icon
453
Norwegian Cruise Line
NCLH
$8.84B
– –
-111,979
Closed -$2.76M
NCNO icon
454
nCino
NCNO
$2.1B
– –
-7,876
Closed -$214K
NTNX icon
455
Nutanix
NTNX
$16.9B
– –
-3,763
Closed -$280K
NTR icon
456
Nutrien
NTR
$30.7B
– –
-3,447
Closed -$202K
NWSA icon
457
News Corp Class A
NWSA
$15.4B
– –
-11,296
Closed -$347K
OKTA icon
458
Okta
OKTA
$25.8B
– –
-4,049
Closed -$371K
ONON icon
459
On Holding
ONON
$12.5B
– –
-14,373
Closed -$609K
ORI icon
460
Old Republic International
ORI
$10.4B
– –
-12,076
Closed -$513K
OTIS icon
461
Otis Worldwide
OTIS
$28.2B
– –
-3,340
Closed -$305K
PBH icon
462
Prestige Consumer Healthcare
PBH
$2.6B
– –
-16,960
Closed -$1.06M
PLD icon
463
Prologis
PLD
$133B
– –
-1,900
Closed -$218K
PLNT icon
464
Planet Fitness
PLNT
$3.78B
– –
-56,000
Closed -$5.81M
PMN icon
465
ProMIS Neurosciences
PMN
$132M
– –
-118,981
Closed -$1.26M
PNC icon
466
PNC Financial Services
PNC
$101B
– –
-3,231
Closed -$649K
PNFP icon
467
Pinnacle Financial Partners Inc
PNFP
$15.8B
– –
-3,141
Closed -$295K
PSA icon
468
Public Storage
PSA
$61.3B
– –
-1,973
Closed -$570K
RACE icon
469
Ferrari
RACE
$72.5B
– –
-622
Closed -$302K
REZI icon
470
Resideo Technologies
REZI
$3.95B
– –
-17,781
Closed -$768K
RGEN icon
471
Repligen
RGEN
$9.25B
– –
-2,367
Closed -$316K
RL icon
472
Ralph Lauren
RL
$23.6B
– –
-884
Closed -$277K
ROKU icon
473
Roku
ROKU
$22.7B
– –
-31,623
Closed -$3.17M
SKYW icon
474
Skywest
SKYW
$4.34B
– –
-6,276
Closed -$631K
SNAP icon
475
Snap
SNAP
$9.01B
– –
-12,881
Closed -$99.3K
17 18
19
20 21

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Armistice Capital held 510 positions worth $8.4B, up 25% from $6.74B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Armistice Capital deployed $1.33B of net new capital in Q4 2025, opening 182 new positions and adding to 113 existing holdings. Its largest new stake was Kenvue: 3,992,196 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $96.3M trimmed.

  • Armistice Capital's largest Q4 2025 buy was Kenvue: 3,992,196 shares worth $68.9M.
  • Armistice Capital added most to Agios Pharmaceuticals in Q4 2025, an estimated $79.7M increase.
  • Armistice Capital's biggest Q4 2025 reduction was Travere Therapeutics, cutting an estimated $96.3M.
  • Armistice Capital fully exited Exact Sciences in Q4 2025, selling an estimated $56.4M.
  • Armistice Capital's ten largest holdings make up 61% of its $8.4B portfolio in Q4 2025.
  • Armistice Capital opened 182 new positions and closed 146 in Q4 2025.
  • Armistice Capital's portfolio value rose 25% quarter-over-quarter to $8.4B.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.